A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma. (Q44230885)
Jump to navigation
Jump to search
scientific article published in December 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma. |
scientific article published in December 2002 |
Statements
A phase II study of outpatient subcutaneous histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma (English)
H Schmidt
S Larsen
K Fode
C Rytter
H Von Der Maase
1 December 2002